A first for CHOC, a team led by Dr. Terence Sanger and Dr. Joffre Olaya treats a teen’s movement disorder through deep brain stimulation.
Investigational Drug Study Leads to FDA Approval for Fenfluramine in Treatment for Dravet Syndrome
Dr. Mary Zupanc was a key investigator in a study that led to FDA approval for a medication to treat children with Dravet syndrome.
Leading-edge biomarker research aids in infantile spasms management
Much of infantile spasms research focuses on visual analysis of a patient’s EEG, whereas Dr. Daniel Shrey’s research uses a computation.
CHOC pioneers medical home for children with autism
The Thompson Autism and Neurodevelopmental Center addresses autism defined core symptoms through a medical home approach that reduces unmet healthcare needs.
CHOC recognized as one of nation’s best children’s hospitals
CHOC is among a select group of pediatric facilities nationwide to be ranked as a best children’s hospital by U.S. News & World Report.
5 things pediatricians should know about seizures
Dr. Mary Zupanc points to five important points pediatricians should consider when seeing a patient who has had one or more seizures.
